Evogene (EVGN) Current Deferred Revenue (2011 - 2015)

Evogene has disclosed Current Deferred Revenue across 5 years of filings, most recently posting $858000.0 for Q4 2015.

• In Q4 2015, Current Deferred Revenue fell 56.31% year-over-year to $858000.0; the TTM figure through Dec 2015 stood at $858000.0 (down 56.31% YoY), while the FY2015 annual figure was $858000.0, down 56.31% from the prior year.
• Current Deferred Revenue came in at $858000.0 for Q4 2015 at Evogene, down from $2.0 million in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $11.7 million in Q4 2011 to a low of $858000.0 in Q4 2015.
• Average Current Deferred Revenue over 5 years is $5.1 million, with a median of $2.5 million recorded in 2013.
• Year-over-year, Current Deferred Revenue tumbled 69.75% in 2013 and fell 22.52% in 2014.
• Over 5 years, Current Deferred Revenue stood at $11.7 million in 2011, then slipped by 28.45% to $8.4 million in 2012, then plunged by 69.75% to $2.5 million in 2013, then fell by 22.52% to $2.0 million in 2014, then plunged by 56.31% to $858000.0 in 2015.
• Per Business Quant data, the three most recent Current Deferred Revenue figures were $858000.0 in Q4 2015, $2.0 million in Q4 2014, and $2.5 million in Q4 2013.